• S. D. Shapoval
  • I. L. Savon
  • O. O. Maksimova
  • L. A. Vasilevskaja
  • M. M. Sofilkanich
  • O. V. Tribushnoj
Keywords: diabetes mellitus, sepsis.


Summary. Introduction Every year, 18–20 million cases of sepsis are recorded in the world, 30 % of which result in death. Hopes that with the development of sanitary-hygienic measures the dynamics of sepsis will decrease, turned out to be illusory. The annual increase in the frequency of sepsis is 8.7 %, while it is noted that the number of patients with impaired carbohydrate metabolism increases by 8-27 %.

Materials and methods. 5612 case histories of patients with purulent-septic diseases who were treated at the center for the period 2015-2019 were analyzed.

Results. It was found that 213 (3.8 %) patients had diabetes mellitus (DM) type I or II (group 1), and the number of patients with complicated diabetic foot syndrome (SDS) was 43.3 % of the total number of patients (2431 patients) — 2 group. The development of sepsis in patients of the 1st group was recorded in 1.4 % of cases (46 patients), while in patients with complicated SDS — in 8.3 % (202 patients). Among the latter, in the overwhelming majority of cases, the starting point in the development of sepsis was “wet” gangrene of the lower extremities.

Conclusions. In patients with diabetes, the risk of developing septic complications is significantly higher than in patients without impaired carbohydrate metabolism.


1. Assessment of clinical criteria for sepsis. JAMA, doi: 10.1001/jama. 2016.0288. Seymour CW, Liu V, Iwashyna TJ, et al.
2. Assessment of definition and clinical criteria for septic shock. JAMA.doi: 10.1001/jama.2016.0289. Shankar-Hari M, Philips G, Levy ML, et al.
3. Богун Л.В. Инфекции у больных сахарным диабетом. Болезни и антибиотики. 2009;1:24-29.
4. Byrne L., Van Haren F. Fluid resuscitation in human sepsis: Time to rewrite history? Ann Intensive Care. 2017; 7: 4. Published online 2017 Yan 3. doi: 10.1186/sl 3613-016-0231-8.
5. Fiesclag J, Ajalat G, Busuttil R. Treatment of necrotizing soft tissue infections. Am J Surg. 1985;149:751-755.
6. Fluid resuscitation in human sepsis: Time to rewrite history? / L. Byrne, F. Van Haren Ann Intensive Care. 2017; 7: 4. Published online 2017 Yan 3. doi: 10.1186/sl3613-016-0231-8.
7. King JTJr, Goulet JL, Perkal MF, Rosenthal RA. Glycemic control and infections in patients with diabetes undergoing noncardiac surgery. Ann Surg. 2011;253:158-165.
8. Koh GCKW, Peacock SJ, van der Poil T, Wiersinga WJ. The impact of diabetes on the pathogenesis of sepsis. Eur J Clin Microbiol Infect Dis. 2012;31:379-388.
9. Liesenfeld O., Lehman L., Hunfeld K.P., Kost G. Molecular diagnosis of sepsis: New aspects and recent developments Eur.J. Microbiol. Immunol. 2014; 4(1): 1-25.dоі: 10.1556/EuJMI. 4. 2014.1.1.
10. Marik P., Bellomo R. A rational approach to fluid therapy in sepsis British Journal of Anaesthosia. 2016; 116 (3): 339-49. doi:10.1093/bjalaev349.
11. Muller LMAJ, Gorter KJ, Hak E et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005;41:281-288.
12. Myurrey, P. Molekulyamyie i nemolekulyamyie metodyi v diagnostike infektsiy krovotoka [Molecular and non-molecular methods in the diagnosis of bloodstream infections]. Simpozium: “Sepsis i infektsii krovotoka”. - XVI Mezhdunarodnyiy kongress MAKMAX po antimikrobnoy terapii [Symposium: “Sepsis and bloodstream infection.” - XVI International Congress of MAKMAX on antimicrobial therapy]. Moscow, 2014. [in Russian].
13. Shapoval S.D, Trybushnyi O.V., Savon I.L., Novak V.V. Analiz letalnosti za uskladnenoho syndromu diabetychnoi stopy ta sepsysu / Klinichna khirurhiia. - 2017 № 1. - S. 58-60.[inUkranian].
14. Singer M., Deutschman C.S., Seymour C.W. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) .YAMA. 2016; 315(8) : 801-10. doi:10.1001/jama.2016.0287
15. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 RhodesA., EvansL.E., AlhazzaniW. etal. Intensive Care Med.-2017.-P. 1-74. DOI: 10.1007 / s00134-017-4683-6.
16. Won Dac Park., Zmijewski Y. Mitochondrial Dysfunction and Immune Cell Metabolism in Sepsis Infection &Chemotherapy.2017;49(l):10-21. doi: 10.3947/ic.2017.49.1.10
How to Cite
Shapoval, S. D., Savon, I. L., Maksimova, O. O., Vasilevskaja, L. A., Sofilkanich, M. M., & Tribushnoj, O. V. (2020). DISRUPTION OF CARBOHYDRATE METABOLISM IN PATIENTS WITH SEPSIS. Kharkiv Surgical School, (1), 46-50. https://doi.org/10.37699/2308-7005.1.2020.04